InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Jin Medical International Ltd.

ZJYL Clue Score34
China Fiscal year ends September CIK 0001837821
$2.20 +6.80% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.20 −87.58% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 28 Mar 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue20.8Operating income2.6Net income2.6EPS, diluted0.02Fiscal year 2022Revenue19.2 −7.6%Operating income2.1Net income2.7 +2.8%EPS, diluted0.02 +0.0%Fiscal year 2023Revenue19.8 +3.3%Operating income2.9Net income2.9 +6.3%EPS, diluted0.02 +0.0%Fiscal year 2024Revenue23.5 +18.6%Operating income3.6Net income3.7 +27.7%EPS, diluted0.02 +0.0%Fiscal year 2025Revenue20.7 −12.0%Operating income0.6Net income1.2 −67.6%EPS, diluted0.01 −50.0%
FY2021FY2022FY2023FY2024FY2025
Revenue 20.8 19.2 19.8 23.5 20.7
Growth −7.6% +3.3% +18.6% −12.0%
Operating income 2.6 2.1 2.9 3.6 0.6
Net income 2.6 2.7 2.9 3.7 1.2
Growth +2.8% +6.3% +27.7% −67.6%
EPS, diluted 0.02 0.02 0.02 0.02 0.01
Growth +0.0% +0.0% +0.0% −50.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Gross margin30.6%Operating margin12.7%Net margin12.7%Free cash flow margin27.9%Fiscal year 2022Gross margin32.3%Operating margin11.1%Net margin14.1%Free cash flow margin8.0%Fiscal year 2023Gross margin34.2%Operating margin14.5%Net margin14.5%Free cash flow margin15.1%Fiscal year 2024Gross margin40.4%Operating margin15.5%Net margin15.6%Free cash flow margin−5.8%Fiscal year 2025Gross margin29.2%Operating margin2.9%Net margin5.8%Free cash flow margin−18.0%
FY2021FY2022FY2023FY2024FY2025
Gross margin 30.6% 32.3% 34.2% 40.4% 29.2%
Operating margin 12.7% 11.1% 14.5% 15.5% 2.9%
Net margin 12.7% 14.1% 14.5% 15.6% 5.8%
Free cash flow margin 27.9% 8.0% 15.1% −5.8% −18.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow5.8Capital expenditure−0.0Free cash flow5.8Fiscal year 2022Operating cash flow1.6Capital expenditure−0.0Free cash flow1.5 −73.4%Fiscal year 2023Operating cash flow3.1Capital expenditure−0.1Free cash flow3.0 +94.3%Fiscal year 2024Operating cash flow−1.2Capital expenditure−0.1Free cash flow−1.4 −145.2%Fiscal year 2025Operating cash flow2.9Capital expenditure−6.6Free cash flow−3.7
FY2021FY2022FY2023FY2024FY2025
Operating cash flow 5.8 1.6 3.1 −1.2 2.9
Capital expenditure −0.0 −0.0 −0.1 −0.1 −6.6
Free cash flow 5.8 1.5 3.0 −1.4 −3.7
Growth −73.4% +94.3% −145.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2021Cash and securities3.7Shareholders’ equity14.0Fiscal year 2022Cash and securities7.1Shareholders’ equity15.2Fiscal year 2023Cash and securities16.7Total debt4.1Net cash (debt)12.6Shareholders’ equity24.0Debt to equity0.17Fiscal year 2024Cash and securities26.8Total debt11.3Net cash (debt)15.4Shareholders’ equity28.8Debt to equity0.39Fiscal year 2025Cash and securities29.6Total debt18.8Net cash (debt)10.8Shareholders’ equity29.6Debt to equity0.64
FY2021FY2022FY2023FY2024FY2025
Cash and securities 3.7 7.1 16.7 26.8 29.6
Total debt n/a n/a 4.1 11.3 18.8
Net cash (debt) n/a n/a 12.6 15.4 10.8
Shareholders’ equity 14.0 15.2 24.0 28.8 29.6
Debt to equity n/a n/a 0.17 0.39 0.64

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025 30 Sep 2025
Revenue and profit
20.8 19.2 19.8 23.5 20.7
Growth −7.6% +3.3% +18.6% −12.0%
14.4 13.0 13.0 14.0 14.6
6.4 6.2 6.8 9.5 6.0
Growth −2.6% +9.5% +40.1% −36.4%
1.6 1.9 1.5 1.5 1.6
1.7 1.8 1.9 3.3 2.5
2.6 2.1 2.9 3.6 0.6
Growth −19.0% +34.6% +26.9% −83.3%
2.9 2.7 3.2 4.2 1.6
0.2 0.0 0.3 0.8 0.2
2.6 2.7 2.9 3.7 1.2
Growth +2.8% +6.3% +27.7% −67.6%
Per share
0.02 0.02 0.02 0.02 0.01
0.02 0.02 0.02 0.02 0.01
Growth +0.0% +0.0% +0.0% −50.0%
135.0 135.0 145.1 156.5 156.5
135.0 135.0 145.1 156.5 156.5
Growth +0.0% +7.5% +7.8% +0.0%

Five years in brief

Worked out from the figures above, not from a press release
  • Profitable in every one of the 5 years on file.